[HTML] nih.gov

COVID-19 in immunocompromised hosts: what we know so far

M Fung, JM Babik - Clinical Infectious Diseases, 2021 - academic.oup.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused significant morbidity and …
被引用次数：502 相关文章 所有 10 个版本
[HTML] nih.gov

[HTML][HTML] COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies

JD Goldman, PC Robinson, TS Uldrick… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
SARS-CoV-2 is the virus responsible for the COVID-19 pandemic. COVID-19 has highly
variable disease severity and a bimodal course characterized by acute respiratory viral …
被引用次数：104 相关文章 所有 12 个版本
[HTML] plos.org

[HTML][HTML] COVID-19-related outcomes in immunocompromised patients: A nationwide study in Korea

MS Baek, MT Lee, WY Kim, JC Choi, SY Jung - PloS one, 2021 - journals.plos.org
Background Given the rapid increased in confirmed coronavirus disease 2019 (COVID-19)
and related mortality, it is important to identify vulnerable patients. Immunocompromised …
被引用次数：57 相关文章 所有 11 个版本
[HTML] sciencedirect.com

[HTML][HTML] COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients

JA Belsky, BP Tullius, MG Lamb, R Sayegh, JR Stanek… - Journal of Infection, 2021 - Elsevier
Background The clinical impact of severe coronavirus disease 2019 (COVID-19), caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in immunocompromised …
被引用次数：205 相关文章 所有 9 个版本
[HTML] nih.gov

[HTML][HTML] Impacts of immunosuppression and immunodeficiency on COVID-19: A systematic review and meta-analysis

Y Gao, Y Chen, M Liu, S Shi, J Tian - The Journal of infection, 2020 - ncbi.nlm.nih.gov
Minotti Chiara and colleagues recently published a systematic review that investigated the
current knowledge on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
被引用次数：204 相关文章 所有 6 个版本
[HTML] nih.gov

[HTML][HTML] COVID-19 disease severity among people with HIV infection or solid organ transplant in the United States: a nationally-representative, multicenter …

J Sun, RC Patel, Q Zheng, V Madhira, AL Olex… - Medrxiv, 2021 - ncbi.nlm.nih.gov
Background Individuals with immune dysfunction, including people with HIV (PWH) or solid
organ transplant recipients (SOT), might have worse outcomes from COVID-19. We …
被引用次数：41 相关文章 所有 11 个版本
[PDF] monash.edu

The risk and impact of COVID-19 pandemic on immunosuppressed patients: cancer, HIV, and solid organ transplant recipients

AH Mohammed, A Blebil, J Dujaili… - AIDS …, 2020 - research.monash.edu
Toward the end of the year 2019, there was the eruption of an acute respiratory syndrome,
which is widely referred as coronavirus disease (COVID-19) from Wuhan, Hubei Province …
被引用次数：54 相关文章 所有 7 个版本
[HTML] nih.gov

Immunosuppression as a risk factor for COVID‐19: a meta‐analysis

D Tassone, A Thompson, W Connell… - Internal Medicine …, 2021 - Wiley Online Library
Background While immunosuppression poses a theoretical increase in the risk of COVID‐
19, the nature of this relationship is yet to be ascertained. Aims To determine whether …
被引用次数：39 相关文章 所有 8 个版本
[HTML] plos.org

[HTML][HTML] Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study

L Turtle, M Thorpe, TM Drake, M Swets… - PLoS …, 2023 - journals.plos.org
Background Immunocompromised patients may be at higher risk of mortality if hospitalised
with Coronavirus Disease 2019 (COVID-19) compared with immunocompetent patients …
被引用次数：45 相关文章 所有 23 个版本
[PDF] sciencedirect.com

SARS-CoV-2 in immunocompromised individuals

S DeWolf, JC Laracy, MA Perales, M Kamboj… - Immunity, 2022 - cell.com
Immunocompromised individuals and particularly those with hematologic malignancies are
at increased risk for SARS-CoV-2-associated morbidity and mortality due to immunologic …
被引用次数：72 相关文章 所有 8 个版本